Ji Xia, Dong Aisheng, Wang Yang
From the Department of Gastroenterology, The Second Affiliated Hospital, Jiaxing University, Jiaxing, Zhejiang Province.
Department of Nuclear Medicine, Changhai Hospital, Naval Medical University.
Clin Nucl Med. 2024 Jan 1;49(1):e42-e44. doi: 10.1097/RLU.0000000000004952. Epub 2023 Nov 16.
Malignant transformation of heterotopic pancreas is extremely rare. We describe FDG PET/CT findings in a case of pancreatic ductal adenocarcinoma arising from a heterotopic pancreas in the submucosa of the pylorus with peripyloric lymph node metastasis and elevated serum carbohydrate antigen 19-9 level. The heterotopic pancreatic adenocarcinoma showed intense FDG uptake, and the peripyloric lymph node metastasis showed mild FDG uptake. This case indicates that heterotopic pancreatic adenocarcinoma should be included in the differential diagnosis of FDG-avid gastric submucosal lesions, especially in patients with elevated serum carbohydrate antigen 19-9 level.
异位胰腺的恶性转化极为罕见。我们描述了一例起源于幽门黏膜下异位胰腺的胰腺导管腺癌伴幽门周围淋巴结转移及血清糖类抗原19-9水平升高的FDG PET/CT表现。异位胰腺腺癌表现为强烈的FDG摄取,而幽门周围淋巴结转移表现为轻度FDG摄取。该病例表明,异位胰腺腺癌应纳入FDG摄取阳性的胃黏膜下病变的鉴别诊断,尤其是血清糖类抗原19-9水平升高的患者。